{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:28:00Z","timestamp":1789525680931,"version":"build-2803163510"},"reference-count":22,"publisher":"Nihon University School of Dentistry","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Sci"],"published-print":{"date-parts":[[2009]]},"DOI":"10.2334\/josnusd.51.407","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T06:00:08Z","timestamp":1253772008000},"page":"407-410","source":"Crossref","is-referenced-by-count":8,"title":["Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin"],"prefix":"10.2334","volume":"51","author":[{"given":"Giuseppe A.","family":"Scardina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1160","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Akpan A, Morgan R (2002) Oral candidiasis. Postgrad Med J 78, 455-459.","DOI":"10.1136\/pmj.78.922.455"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Holmstrup P, Vedtofte P, Reibel J, Stoltze K (2006) Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42, 461-474.","DOI":"10.1016\/j.oraloncology.2005.08.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Blomhoff R, Blomhoff HK (2006) Overview of retinoid metabolism and function. J Neurobiol 66, 606-630.","DOI":"10.1002\/neu.20242"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Badauy CM, Barbachan JJ, Rados PV, Sant'ana Filho M, Chies JA (2005) Relationship between Candida infection and immune cellular response in inflammatory hyperplasia. Oral Microbiol Immunol 20, 89-92.","DOI":"10.1111\/j.1399-302X.2004.00194.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Warnakulasuriya S (2000) Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol 36, 340-346.","DOI":"10.1016\/S1368-8375(00)00011-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lippman SM, Lee JJ, Martin JW, El-Naggar AK, Xu X, Shin DM, Thomas M, Mao L, Fritsche HA Jr, Zhou X, Papadimitrakopoulou V, Khuri FR, Tran H, Clayman GL, Hittelman WN, Hong WK, Lotan R (2006) Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res 12, 3109-3114.","DOI":"10.1158\/1078-0432.CCR-05-2636"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nagao T, Warnakulasuriya S, Ikeda N, Fukano H, Fujiwara K, Miyazaki H (2000) Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. J Med Screen 7, 203-208.","DOI":"10.1136\/jms.7.4.203"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Njar VC, Gediya L, Purushottamachar P, Chopra P, Vasaitis TS, Khandelwal A, Mehta J, Huynh C, Belosay A, Patel J (2006) Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem 14, 4323-4340.","DOI":"10.1016\/j.bmc.2006.02.041"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Williams DW, Bartie KL, Potts AJ, Wilson MJ, Fardy MJ, Lewis MA (2001) Strain persistence of invasive Candida albicans in chronic hyperplastic candidosis that underwent malignant change. Gerondology 18, 73-78.","DOI":"10.1111\/j.1741-2358.2001.00073.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Scardina GA, Messina P, Carini F, Maresi E (2006) A randomized trial assessing the effectiveness of different concentrations of isotretinoin in the management of lichen planus. Int J Oral Maxillofac Surg 35, 67-71.","DOI":"10.1016\/j.ijom.2005.05.003"},{"key":"11","unstructured":"11. Scardina GA, Fuca G, Ruggieri A, Carini F, Cacioppo A, Valenza V, Messina P (2007) Oral candidiasis and oral hyperplastic candidiasis: clinical presentation. Res J Biol Sci 2, 408-412."},{"key":"12","unstructured":"12. Cawson RA, Binnie WH, Barrett AW, Wright JM (2001) Oral disease. 3rd ed, Mosby, Edinburgh, 8-13."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Dorko E, Zibr&iacute;n M, Jenca A, Pilipcinec E, Danko J, Tk&aacute;cikov&aacute; L (2001) The histopathological characterization of oral <I>Candida leukoplakias<\/I>. Folia Microbiol (Praha) 46, 447-451.","DOI":"10.1007\/BF02814437"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Liu X, Hua H (2007) Oral manifestation of chronic mucocutaneous candidiasis: seven case reports. J Oral Pathol Med 36, 528-532.","DOI":"10.1111\/j.1600-0714.2007.00572.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sitheeque MA, Samaranayake LP (2003) Chronic hyperplastic candidosis\/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med 14, 253-267.","DOI":"10.1177\/154411130301400403"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA (2001) PCR fingerprinting of <I>Candida albicans<\/I> associated with chronic hyperplastic candidosis and other oral conditions. J Clin Microbiol 39, 4066-4075.","DOI":"10.1128\/JCM.39.11.4066-4075.2001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nagao T, Ikeda N, Warnakulasuriya S, Fukano H, Yuasa H, Yano M, Miyazaki H, Ito Y (2000) Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese. Oral Oncol 36, 466-470.","DOI":"10.1016\/S1368-8375(00)00037-3"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2001.300502.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zanardi S, Serrano D, Argusti A, Barile M, Puntoni M, Decensi A (2006) Clinical trials with retinoids for breast cancer chemoprevention. Endocr Relat Cancer 13, 51-68.","DOI":"10.1677\/erc.1.00938"},{"key":"20","unstructured":"20. Scardina GA, Ruggieri A, Carini F, Cacioppo A, Valenza V, Messina P (2007) Evaluation of the serum levels of retinol in patients affected by leukoplakia and oral lichen planus: a statistical analysis. Res J Biol Sci 2, 383-386."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Scardina GA, Carini F, Maresi E, Valenza V, Messina P (2006) Evaluation of the clinical and histological effectiveness of isotretinoin in the therapy of oral leukoplakia: ten years of experience: is management still up to date and effective? Methods Find Exp Clin Pharmacol 28, 115-119.","DOI":"10.1358\/mf.2006.28.2.977843"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. B&eacute;rard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D (2007) Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol 63, 196-205.","DOI":"10.1111\/j.1365-2125.2006.02837.x"}],"container-title":["Journal of Oral Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/josnusd\/51\/3\/51_3_407\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T18:51:03Z","timestamp":1710615063000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/josnusd\/51\/3\/51_3_407\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2334\/josnusd.51.407","relation":{},"ISSN":["1880-4926","1343-4934"],"issn-type":[{"value":"1880-4926","type":"electronic"},{"value":"1343-4934","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}